6th Annual GUILD Conference Program<\/h1>\n<\/blockquote>\n
Gastroenterology Updates IBD and Liver Disease 2022 Program<\/span><\/strong><\/p>\n Saturday February 19, 2022 – Registration from 2 PM to 6 PM [\/et_pb_text][et_pb_text _builder_version=”4.14.7″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n Questions: 9:20-9:30<\/em><\/td>\n Questions: 10:00-10:05<\/em><\/td>\n Questions: 10:35-10:40<\/em><\/td>\n Questions: 11:40-11:45<\/em><\/td>\n Questions: 12:20-12:25<\/em><\/td>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.10.8″ _module_preset=”default” custom_padding=”35px||0px||false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.10.8″ _module_preset=”default” custom_padding=”0px||||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.10.8″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.11.3″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n Breakfast and Breaks: Posters and Exhibits: Year in Review:<\/strong> \u201cOutside the Box\u201d and Special Seminars:<\/strong> \u201cHow I do it\u201d Seminar:<\/strong> Hot Topic:<\/strong> Guidelines:<\/strong> Ask the Consultant:<\/strong> The Hot Seat:<\/strong> Advances:<\/strong> Improving Quality of Care:<\/strong> Panel Discussions:<\/strong> Afternoon Workshops:<\/strong> [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Questions Section” _builder_version=”4.10.8″ _module_preset=”default” custom_padding=”0px||0px||true|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.10.8″ _module_preset=”default” custom_padding=”0px||0px||true|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.10.8″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.11.3″ _module_preset=”default” custom_padding=”0px||0px||true|false” global_colors_info=”{}”]<\/p>\n![\"guild](\"https:\/\/guildconference.com\/2022\/wp-content\/uploads\/2022\/02\/guild-time-zone-bar.jpg\")
<\/p>\nGUILD BOOTCAMP: Back to Basics (All Registered Attendees Welcome)<\/h5>\n
<\/strong><\/p>\n\n
\n\n
\n Time (HST)<\/strong><\/span><\/th>\n Sunday (2\/20\/22)<\/strong><\/span><\/th>\n Monday (2\/21\/22)<\/strong><\/span><\/th>\n Tuesday (2\/22\/22)<\/strong><\/span><\/th>\n Wednesday (2\/23\/22)<\/strong><\/span><\/th>\n<\/tr>\n \n Non-CME
\n7:00 – 8:00 AM<\/strong><\/td>\nProduct Theater Breakfast hosted by AbbVie<\/strong>
\nProgressing the Care of IBD
\n.<\/span>
\n<\/em>David Schwartz, MD, FACG, AGAF<\/em><\/td>\nProduct Theater Breakfast hosted by Janssen<\/strong>
\nSTELARA\u00ae (ustekinumab) FOR ULCERATIVE COLITIS (UC)
\n.<\/span>
\nCharles A. Sninsky MD<\/em><\/td>\nProduct Theater Breakfast hosted by Pfizer<\/strong>
\nA Clinical Overview of a Prescription Treatment for Patients With Moderately
\nto Severely Active Ulcerative Colitis
\n.<\/span>
\nAsher Kornbluth, MD<\/em><\/td>\n<\/td>\n<\/tr>\n \n 7:30 – 8:30 AM<\/strong><\/td>\n Breakfast with faculty:
\n<\/strong>Posters \/ Exhibits
\n(Intro starts 8:15 am)<\/td>\nBreakfast with Faculty:<\/strong>
\nPosters \/ Exhibits<\/td>\nBreakfast with Faculty:<\/strong>
\nPosters \/ Exhibits<\/td>\nBreakfast with Faculty:<\/strong>
\nPosters \/ Exhibits<\/td>\n<\/tr>\n\n 8:30 – 9:20 AM<\/strong><\/p>\n Year in Review:<\/strong>
\nCrohns Disease
\n.<\/span>
\nEdward Loftus, MD
\nWilliam Sandborn, MD<\/em><\/td>\nYear in Review:<\/strong>
\nChronic Liver Diseases
\n.<\/span>
\nNorah Terrault, MD
\nElliott Tapper, MD<\/em><\/td>\nYear in Review:<\/strong>
\nUlcerative Colitis
\n.<\/span>
\nDavid Rubin, MD
\nFernando Velayos, MD<\/em><\/td>\nWednesday Morning Office Hours:
\nYear in Review:<\/strong>
\nBest Papers in Gastroenterology 2021
\n.<\/span>
\nDavid Lieberman, MD
\nDoug Corley, MD<\/em><\/td>\n<\/tr>\n\n 9:30 – 10:00 AM<\/strong><\/p>\n Improving Quality of Care:<\/strong>
\nA Practical Guide to Incorporating Treat to Target into your Practice
\n.<\/span>
\nDavid Rubin, MD
\n<\/em><\/td>\nState of the Art:<\/strong>
\nManagement of Ascites and its Complications in 2022
\n.<\/span>
\nLupe Garica Tsao, MD<\/em><\/td>\nHot Topic:<\/strong>
\nSafety of IBD Medication During Conception\/Pregnancy for Men and Women with IBD
\n.<\/span>
\nUma Mahadevan, MD<\/em><\/td>\nGuidelines:<\/strong>
\nThe Patient with Diverticular Disease
\n.<\/span>
\nAasma Shaukat, MD<\/em><\/td>\n<\/tr>\n\n 10:05 – 10:35 AM<\/strong><\/p>\n How I Do It:<\/strong>
\nThe Management of Perianal Fistulizing Disease
\n.<\/span>
\nMiguel Regueiro, MD<\/em><\/td>\nHow I Do It:<\/strong>
\nViral Hepatitis for the Gastroenterologist
\n.<\/span>
\nNorah Terrault, MD<\/em><\/td>\nAsk the Consultant:<\/strong>
\nThe IBD Patient with a Rash!
\n.<\/span>
\nGeorge Martin MD<\/em><\/td>\nImproving Quality of Care:
\n<\/strong>Current and Future Trends in CRC Screening Tests
\n.<\/span>
\nDavid Lieberman, MD<\/em><\/td>\n<\/tr>\n\n 10:40 – 11:10 AM<\/strong><\/span><\/th>\n Break \/ Exhibits<\/span><\/th>\n Break \/ Exhibits<\/span><\/th>\n Break \/ Exhibits<\/span><\/th>\n Break \/ Exhibits<\/span><\/th>\n<\/tr>\n \n 11:10 – 11:40 AM<\/strong><\/p>\n Ask the Consultant:<\/strong>
\nThe IBD Patient with Joint Pain!
\n.<\/span>
\nArthur Kavanaugh, MD<\/em><\/td>\nState of the Art:<\/strong>
\nUpdate on the Treatment of NASH
\n.<\/span>
\nManal Abdelmalek, MD<\/em><\/td>\nOut of the Box:<\/strong>
\nPreventive Health in IBD
\n.<\/span>
\nMillie Long, MD<\/em><\/td>\nAsk the Consultant:<\/strong>
\nThe Patient with Abnormal Liver Tests
\n.<\/span>
\nManal Abdelmalek, MD<\/em><\/td>\n<\/tr>\n\n 11:45 AM – 12:20 PM<\/strong><\/p>\n State of the Art:<\/strong>
\nHow to Position Biologic\/Small Molecule Therapies in your Practice: Balancing Safety and Efficacy
\n.<\/span>
\nMillie Long, MD<\/em><\/td>\nHot Seat:<\/strong>
\nHCC Surveillance: Who, How and Anticipated Benefits
\n.<\/span>
\nElliott Tapper, MD<\/em><\/td>\nState of the Art:
\n<\/strong>COVID and IBD: Lessons Learned
\n.<\/span>
\nMiguel Regueiro, MD<\/em><\/td>\nHot Topic:
\n<\/strong>Should You Stop the PPI?
\n.<\/span>
\nDoug Corley, MD<\/em><\/strong><\/em><\/td>\n<\/tr>\n\n 12:25 – 12:45 PM<\/strong><\/span><\/th>\n Break<\/span><\/th>\n Break<\/span><\/th>\n Break<\/span><\/th>\n Break<\/span><\/th>\n<\/tr>\n \n 12:45 – 1:20 PM
\n<\/strong>\u201cLunch & Lecture\u201d
\nTicket RequiredQuestions: 1:20-1:30<\/em><\/td>\nAdvances:<\/strong>
\nPrecision Medicine in IBD
\n.<\/span>
\nMichael Kattah, MD
\n<\/em><\/td>\nImproving Quality of Care:<\/strong>
\nTips on TIPS
\n.<\/span>
\nLupe Garcia Tsao, MD<\/em><\/td>\nHot Topic:<\/strong>
\nBiosimilars in IBD
\n.<\/span>
\nFernando Velayos, MD<\/em><\/td>\nAdvances in GI:<\/strong>
\nChemoprevention in GI Cancer: Is there a Role?
\n.<\/span>
\nAasma Shaukat, MD
\n<\/em><\/td>\n<\/tr>\n\n 1:30 – 3:30 PM<\/strong>
\nAfternoon Workshops<\/td>\nCases with the Faculty:<\/strong>
\nCase Based IBD Review
\n.<\/span>
\nUma Mahadevan, MD and IBD faculty<\/em><\/td>\nLiver Jeopardy:<\/strong>
\n.<\/span>
\nNorah Terrault, MD and all Liver faculty<\/em><\/td>\nHow I Do It:<\/strong>
\n<\/em>\u2022 PSC-IBD: Diagnosis and Management (30 in)
\nEdward Loftus, MD
\n<\/em>\u2022 IBS-IBD: Managing the Overlap (30 min)
\nAline Charabaty, MD<\/em>
\n\u2022 Questions to the Faculty<\/td>\nMeeting Closure<\/strong><\/td>\n<\/tr>\n \n Non-CME
\n5:00 – 6:00 PM<\/strong><\/td>\n<\/td>\n <\/td>\n Product Theater Dinner hosted by BMS
\n<\/strong>ZEPOSIA\u2122 (Ozanimod): A Once-Daily Oral S1P Receptor Modulator for the
\nTreatment of Moderately to Severely Active Ulcerative Colitis in Adults
\n.<\/span>
\nUma Mahadevan, MD<\/em><\/td>\n<\/td>\n<\/tr>\n \n 6:00 – 9:00 PM<\/span><\/strong><\/th>\n Welcome Reception & Dinner<\/span><\/th>\n <\/th>\n <\/th>\n <\/th>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n Activities<\/h4>\n
<\/strong>At the breakfast session and at the breaks between sessions, attendees will have the opportunity to review poster presentations, interact with the authors, and view the exhibit area. Faculty will be in the breakfast area meeting informally with the attendees.<\/p>\nSession Descriptions<\/h4>\n
Two speakers will have about 15 minutes each to present and defend their choice for the important papers\/abstracts\/news stories\/etc. from the previous year on key topics. At the end, there will be 10 minutes available for audience Q&A and discussion.<\/p>\n
One speaker will cover a topic relevant to but perhaps outside of traditional gastroenterology topics. 30 minutes for lecture, 10 minutes for Q&A.<\/p>\n
One speaker will cover a topic in gastroenterology from their expert personal perspective, supplemented by literature review, and presented in case format for 20 minutes with 10 minutes for Q&A.<\/p>\n
One speaker will cover a topic of particular new relevance to gastroenterologists, presenting the latest evidence, recommendations, etc. 20-30 minutes for lecture, 10 minutes for Q&A.<\/p>\n
Review of society guidelines on key topic by leading expert. 30 minute talk with 10 minutes for audience Q+A.<\/p>\n
A gastroenterologist will be able to present short, common cases to a non-GI specialist for their practical advice. This year, we will quiz a rheumatologist on disease and drug related arthralgias and rheumatic events in IBD.<\/p>\n
One faculty member presents cases to a panel of faculty and to the audience to stimulate discussion on approaches to challenging cases.<\/p>\n
Talks will address both technologic and therapeutic advances in topic areas.<\/p>\n
\u201cQuality\u201d is a buzzword in medicine today. This series addresses specific topics where providers can troubleshoot and improve their patient care.<\/p>\n
All faculty and the audience members participate and give their assessment of and opinions on key topics in our field.<\/p>\n
These 110 minute sessions will cover practical issues relevant to the clinic. The format will be hands on or video, with subjects, supplemented by a lecture and discussion, with the goal of allowing clinicians to learn about novel techniques or participate in complex case discussion.<\/p>\n\n
Questions?<\/h4>\n